Medfinder
Back to blog

Updated: January 18, 2026

Synarel Shortage Update: What Patients Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Calendar and medication bottle with availability graph for Synarel shortage update

Synarel isn't on the FDA shortage list in 2026, but availability gaps persist. Here's what patients with endometriosis or CPP need to know about finding it.

If you take Synarel for endometriosis or central precocious puberty (CPP), you may have noticed it isn't always easy to find. Patients across the US regularly report difficulty getting their prescriptions filled — not because of an official FDA shortage, but because of the unique distribution challenges that come with a brand-only specialty medication.

This update covers the current status of Synarel availability in the United States in 2026, what happened internationally, and what you should do if your pharmacy can't fill your prescription.

Is Synarel in an Official FDA Shortage in 2026?

As of 2026, Synarel (nafarelin acetate) is NOT on the FDA's official drug shortage list. The FDA shortage database tracks medications where supply has fallen critically short relative to demand — and Synarel has not reached that threshold in the US market.

However, "not in official shortage" does not mean "readily available at every pharmacy." Synarel is a brand-only specialty drug with no US generic equivalent. Many pharmacies simply don't carry it because of its high wholesale cost and limited local demand. This creates persistent localized availability gaps that can feel like a shortage to individual patients.

What Happened to Synarel Internationally?

In late 2022, Synarel experienced documented shortages in the United Kingdom. Nafarelin 200 mcg/dose nasal spray was formally listed as out of stock by the UK Department of Health and Social Care. The shortage was attributed in part to regulatory and distribution disruptions related to the Bell v. Tavistock court ruling, which affected pharmacies that had been supplying the medication primarily for gender dysphoria treatment.

Australia also faced limited availability around the same period, with the Therapeutic Goods Administration (TGA) granting a special import approval for Synarel nasal spray from Canada to address supply constraints.

The US did not experience the same formal shortage at that time, but the international supply disruptions serve as a reminder that Synarel's supply chain is more vulnerable than drugs with multiple manufacturers and generic versions.

Why Synarel Is Hard to Find Even Without an Official Shortage

Several structural factors make Synarel harder to access than the average prescription:

No generic: There is no US generic of nafarelin nasal spray, so only Pfizer's branded product is available.

High price: At $3,100–$3,500 per bottle, community pharmacies rarely stock it without established demand.

Limited prescribing volume: Relatively few patients use nafarelin nasal spray compared to leuprolide, reducing pharmacy stocking motivation.

Specialty channel: Most reliably dispensed through specialty pharmacies rather than general retail pharmacies.

What Should Patients Do If They Can't Fill Synarel?

If your pharmacy tells you Synarel is unavailable or needs to be ordered, here are your best options:

Use medfinder: medfinder calls pharmacies near you to find which ones have Synarel in stock, and texts you the results.

Contact a specialty pharmacy: Specialty pharmacies like CVS Specialty or Walgreens Specialty are more likely to have Synarel or be able to order it quickly.

Ask your prescriber: OB/GYNs and pediatric endocrinologists who regularly prescribe Synarel often know which pharmacies reliably carry it.

Consider clinical alternatives: If Synarel is not available, leuprolide (Lupron), goserelin (Zoladex), or triptorelin (Triptodur) may be appropriate substitutes — with your doctor's guidance.

Will Synarel Have a Generic Available Soon?

As of 2026, no generic nafarelin nasal spray has been approved by the FDA for the US market. There is no publicly announced timeline for generic entry. Until a generic becomes available, patients will continue to depend on the brand-name product from Pfizer, with all the access and cost challenges that entails.

Bottom Line for Synarel Patients in 2026

Synarel is not in an official FDA shortage, but it remains a difficult medication to find at many pharmacies due to its brand-only status, specialty distribution, and high price. Plan ahead, use specialty pharmacies or medfinder, and have a conversation with your prescriber about contingency options before you run out.

Read our guide on how to find Synarel in stock near you for step-by-step strategies.

Frequently Asked Questions

As of 2026, Synarel (nafarelin acetate) is not on the FDA's official drug shortage list in the United States. However, because it is a brand-only specialty medication with no generic equivalent, many community pharmacies do not stock it. Patients may encounter localized availability gaps even without a formal shortage designation.

Synarel was formally listed as out of stock in the United Kingdom in late 2022. Australia also faced availability issues around the same time, requiring special import approvals. The US did not experience a formal FDA shortage at that time, though international supply disruptions raised concerns.

As of 2026, no FDA-approved generic version of Synarel (nafarelin acetate nasal spray) is available in the United States, and there is no publicly announced timeline for generic entry. Patients currently rely on Pfizer's brand-name product.

If Synarel is unavailable, your doctor may recommend leuprolide (Lupron Depot), goserelin (Zoladex), or for CPP, triptorelin (Triptodur) or histrelin (Supprelin LA). For endometriosis, elagolix (Orilissa) is an oral alternative. These are not direct substitutes — always transition under medical supervision.

Synarel's availability challenges are structural, not cyclical — they stem from it being a brand-only drug with no generic competition. Until a generic enters the US market, patients should expect to use specialty pharmacies or services like medfinder to reliably source it.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Synarel also looked for:

33,257 have already found their meds with Medfinder.

Start your search today.

33K+
5-star ratingTrusted by 33,257 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?